Torbenson M - Search Results

1

Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.

Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Munshaw S, et al. Among authors: torbenson m. Hepatology. 2012 Aug;56(2):544-54. doi: 10.1002/hep.25655. Epub 2012 Jul 6. Hepatology. 2012. PMID: 22331678 Free PMC article.

2

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Rai R, et al. Among authors: torbenson m. Hepatology. 2002 May;35(5):1247-55. doi: 10.1053/jhep.2002.33151. Hepatology. 2002. PMID: 11981775

3

Occult hepatitis B.

Torbenson M, Thomas DL. Torbenson M, et al. Lancet Infect Dis. 2002 Aug;2(8):479-86. doi: 10.1016/s1473-3099(02)00345-6. Lancet Infect Dis. 2002. PMID: 12150847 Review.

4

Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB. Gebo KA, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S84-92. doi: 10.1053/jhep.2002.36817. Hepatology. 2002. PMID: 12407580 Review.

5

Treatment of chronic hepatitis C: a systematic review.

Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Chander G, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S135-44. doi: 10.1053/jhep.2002.37146. Hepatology. 2002. PMID: 12407587 Review.

6

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Gebo KA, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S161-72. doi: 10.1053/jhep.2002.36989. Hepatology. 2002. PMID: 12407590 Review.

7

Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.

Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Huang J, Guarino P, Kafrouni M, Diehl AM. Oben JA, et al. Among authors: torbenson m. Hepatology. 2003 Sep;38(3):664-73. doi: 10.1053/jhep.2003.50371. Hepatology. 2003. PMID: 12939593

8

Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection.

Hoofring A, Boitnott J, Torbenson M. Hoofring A, et al. Among authors: torbenson m. J Hepatol. 2003 Nov;39(5):738-41. doi: 10.1016/s0168-8278(03)00413-6. J Hepatol. 2003. PMID: 14568255

9

High prevalence of occult hepatitis B in Baltimore injection drug users.

Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Torbenson M, et al. Hepatology. 2004 Jan;39(1):51-7. doi: 10.1002/hep.20025. Hepatology. 2004. PMID: 14752822

10

Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.

Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. Kannangai R, et al. Among authors: torbenson m. J Viral Hepat. 2004 Jul;11(4):297-301. doi: 10.1111/j.1365-2893.2004.00502.x. J Viral Hepat. 2004. PMID: 15230851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page